Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.77 USD
Change Today 0.00 / 0.00%
Volume 2.0M
ONCY On Other Exchanges
As of 5:20 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

George M. Gill M.D.

Chief Safety Officer and Senior Vice President of Clinical & Regulatory Affairs, Oncolytics Biotech Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 4 different industries.

As of Fiscal Year 2013


Dr. George M. Gill, M.D. serves as the Chief Safety Officer and Senior Vice President of Regulatory Affairs at Oncolytics Biotech Inc. Dr. Gill serves as Senior Vice President, Clinical Development of Medinox, Inc. He served as the Chief Medical Officer and Senior Vice President of Clinical and Regulatory Affairs of Oncolytics Biotech Inc. since July 5 2011 and October 2002 respectively. Dr. Gill serves as Vice President, Clinical and Regulatary Affairs of Genetronics ...

Read Full Background

Corporate Headquarters*

1167 Kensington Crescent NW
Calgary, Alberta T2N 1X7


Phone: 403-670-7377
Fax: 403-283-0858

Board Members Memberships*

There is no Board Members Memberships data available.


Dickinson College
University of Pennsylvania - School of Medicine

Other Affiliations*

Annual Compensation*

Total Annual CompensationC$331,908

Stock Options*

All Other CompensationC$27,382
Total Number of Options463,334

Total Compensation*

Total Annual Cash CompensationC$458,862
Total Short Term CompensationC$331,908
Other Long Term CompensationC$27,382
Total Calculated CompensationC$518,062
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ONCY:US $0.77 USD 0.00


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ONCOLYTICS BIOTECH INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at